Stocks in play: Organigram Holdings Inc.
Announced the closing of its strategic investment in convertible secured debentures, to be purchased in three tranches and valued in the aggregate at $10 million, of Hyasynth Biologicals Inc. a biotechnology company based in Montreal and leader in the field of cannabinoid science and biosynthesis. Organigram Holdings Inc. shares V.OGI are trading unchanged at $7.78.